These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 22486628)

  • 1. The clofibrate saga: a retrospective commentary.
    Oliver M
    Br J Clin Pharmacol; 2012 Dec; 74(6):907-10. PubMed ID: 22486628
    [No Abstract]   [Full Text] [Related]  

  • 2. [Overviews of fibrate].
    Tada N
    Nihon Rinsho; 2001 Mar; 59 Suppl 3():609-17. PubMed ID: 11347141
    [No Abstract]   [Full Text] [Related]  

  • 3. Five-year trial of clofibrate in ischaemic heart disease.
    Dewar HA
    Br Heart J; 1971 Jan; 33(1):145. PubMed ID: 5541898
    [No Abstract]   [Full Text] [Related]  

  • 4. Do lipid lowering drugs reduce the risk of coronary heart disease?
    Pritzker LB
    Crit Rev Clin Lab Sci; 1998 Dec; 35(6):603-21. PubMed ID: 9885777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipid lowering drugs and coronary heart disease.
    Scott PJ
    Drugs; 1975; 10(3):218-25. PubMed ID: 1104340
    [No Abstract]   [Full Text] [Related]  

  • 6. Therapy and clinical trials.
    Jones PH; von Bergmann K
    Curr Opin Lipidol; 1997 Dec; 8(6):329-31. PubMed ID: 9412771
    [No Abstract]   [Full Text] [Related]  

  • 7. Review of primary prevention trials of coronary heart disease.
    Stamler J
    Acta Med Scand Suppl; 1985; 701():100-28. PubMed ID: 3907291
    [No Abstract]   [Full Text] [Related]  

  • 8. Reducing cardiac deaths with hypolipidemic drugs.
    Naito HK
    Postgrad Med; 1987 Nov; 82(6):102-12. PubMed ID: 3313343
    [No Abstract]   [Full Text] [Related]  

  • 9. Current and future therapeutic approaches to hyperlipidemia.
    Farmer JA; Gotto AM
    Adv Pharmacol; 1996; 35():79-114. PubMed ID: 8920205
    [No Abstract]   [Full Text] [Related]  

  • 10. Secondary prevention of coronary heart disease: the role of fibric acids.
    Haffner SM
    Circulation; 2000 Jul; 102(1):2-4. PubMed ID: 10880405
    [No Abstract]   [Full Text] [Related]  

  • 11. Type IIa hyperlipoproteinaemia. An evaluation of four therapeutic regimens.
    Watermeyer GS; Mann JI; Truswell AS; Levy I
    S Afr Med J; 1975 Apr; 49(15):631-4. PubMed ID: 1094562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clofibrate for prevention of myocardial infarction.
    Med Lett Drugs Ther; 1973 Apr; 15(9):37-8. PubMed ID: 4704699
    [No Abstract]   [Full Text] [Related]  

  • 13. A comparison of fenofibrate and clofibrate hypolipidemic effects.
    Daubresse JC
    Acta Clin Belg; 1980; 35(4):227-32. PubMed ID: 7015771
    [No Abstract]   [Full Text] [Related]  

  • 14. Cholesterol, coronaries, clofibrate and death.
    Oliver MF
    N Engl J Med; 1978 Dec; 299(24):1360-2. PubMed ID: 362204
    [No Abstract]   [Full Text] [Related]  

  • 15. [Drug prevention of coronary disease].
    Miettinen TA
    Duodecim; 1972; 88(21):1346-54. PubMed ID: 4570871
    [No Abstract]   [Full Text] [Related]  

  • 16. High death rate from neoplasms in French diabetic and non-diabetic men.
    Balkau B; Charles MA; Eschwège E
    Lancet; 1998 May; 351(9114):1512. PubMed ID: 9605828
    [No Abstract]   [Full Text] [Related]  

  • 17. [Fibric acid derivatives].
    Kinoshita M
    Nihon Rinsho; 1999 Dec; 57(12):2826-30. PubMed ID: 10638220
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The results of animal studies with ciprofibrate, a new orally effective hypolipidemic drug.
    Arnold A; McAuliff JP; Powers LG; Phillips DK; Beyler AL
    Atherosclerosis; 1979 Feb; 32(2):155-63. PubMed ID: 454514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical trial of methyl clofenapate (a derivative of clofibrate) in patients with essential hyperlipidaemias--with special reference to type II (primary) hyperlipidaemia.
    Craig GM; Walton KW
    Atherosclerosis; 1972; 15(2):189-98. PubMed ID: 4579956
    [No Abstract]   [Full Text] [Related]  

  • 20. A co-operative trial in the primary prevention of ischaemic heart disease using clofibrate. Report from the Committee of Principal Investigators.
    Br Heart J; 1978 Oct; 40(10):1069-118. PubMed ID: 361054
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.